Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medicare Part D: a successful start with room for improvement.

Literature DB >> 18430916

Medicare Part D: a successful start with room for improvement.

Dana P Goldman, Geoffrey F Joyce.

Abstract

Mesh：

Year: 2008 PMID： 18430916 PMCID： PMC3767428 DOI： 10.1001/jama.299.16.1954

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

× No keyword cloud information.

6 in total

1. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.

Authors: John Hsu; Vicki Fung; Mary Price; Jie Huang; Richard Brand; Rita Hui; Bruce Fireman; Joseph P Newhouse
Journal: JAMA Date: 2008-04-23 Impact factor: 56.272

2. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

Authors: Jeanne M Madden; Amy J Graves; Fang Zhang; Alyce S Adams; Becky A Briesacher; Dennis Ross-Degnan; Jerry H Gurwitz; Marsha Pierre-Jacques; Dana Gelb Safran; Gerald S Adler; Stephen B Soumerai
Journal: JAMA Date: 2008-04-23 Impact factor: 56.272

3. Pharmacy benefit caps and the chronically ill.

Authors: Geoffrey F Joyce; Dana P Goldman; Pinar Karaca-Mandic; Yuhui Zheng
Journal: Health Aff (Millwood) Date: 2007 Sep-Oct Impact factor: 6.301

4. Unintended consequences of caps on Medicare drug benefits.

Authors: John Hsu; Mary Price; Jie Huang; Richard Brand; Vicki Fung; Rita Hui; Bruce Fireman; Joseph P Newhouse; Joseph V Selby
Journal: N Engl J Med Date: 2006-06-01 Impact factor: 91.245

5. Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

Authors: S B Soumerai; T J McLaughlin; D Ross-Degnan; C S Casteris; P Bollini
Journal: N Engl J Med Date: 1994-09-08 Impact factor: 91.245

6. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.

Authors: Wesley Yin; Anirban Basu; James X Zhang; Atonu Rabbani; David O Meltzer; G Caleb Alexander
Journal: Ann Intern Med Date: 2008-01-07 Impact factor: 25.391

6 in total

5 in total

Medicare Part D: a successful start with room for improvement.

1. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.

2. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

3. Pharmacy benefit caps and the chronically ill.

4. Unintended consequences of caps on Medicare drug benefits.

5. Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

6. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.

1. Medicare part D enrollment in a biracial community-based population of older adults.

2. What if the federal government negotiated pharmaceutical prices for seniors? An estimate of national savings.

3. Preparedness of Americans for the Affordable Care Act.

4. A longitudinal analysis of the lifetime cost of dementia.

5. Plan selection in Medicare Part D: evidence from administrative data.